HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 231 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $650,758 | -86.9% | 17,040 | -86.4% | 0.04% | -84.7% |
| Q1 2022 | $4,980,000 | -38.5% | 124,869 | -38.0% | 0.26% | -46.7% |
| Q4 2021 | $8,094,000 | +373.9% | 201,286 | +379.5% | 0.49% | +410.4% |
| Q3 2021 | $1,708,000 | -23.3% | 41,982 | -14.4% | 0.10% | -20.0% |
| Q2 2021 | $2,226,000 | +15.8% | 49,024 | +6.3% | 0.12% | +9.1% |
| Q1 2021 | $1,923,000 | -8.7% | 46,135 | -6.5% | 0.11% | -27.6% |
| Q4 2020 | $2,107,000 | -60.3% | 49,336 | -75.6% | 0.15% | -12.1% |
| Q3 2020 | $5,311,000 | +107.0% | 202,101 | +111.2% | 0.17% | +162.1% |
| Q2 2020 | $2,566,000 | +68.0% | 95,695 | +12.7% | 0.07% | +65.0% |
| Q1 2020 | $1,527,000 | -14.0% | 84,883 | -15.3% | 0.04% | +60.0% |
| Q4 2019 | $1,776,000 | +462.0% | 100,174 | +391.1% | 0.02% | +525.0% |
| Q3 2019 | $316,000 | – | 20,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |